AlphaCrest Capital Management’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
SCM
AlphaCrest Capital Management's HALO Position: Q4 2022 in Review
AlphaCrest Capital Management sold out of Halozyme (HALO) in Q4 2022, closing a stake of 10,972 shares — an estimated $434K sold.
AlphaCrest Capital Management first reported a position in HALO in Q1 2019 and held it in 12 quarters. The position peaked at $2.14M in Q3 2021. 423 funds tracked by Wall St. Rank hold HALO as of Q4 2022.
- AlphaCrest Capital Management reported no remaining Halozyme position as of Q4 2022 after selling out during the quarter.
- AlphaCrest Capital Management sold 10,972 Halozyme shares in Q4 2022, an estimated $434K.
- AlphaCrest Capital Management first reported a position in Halozyme in Q1 2019 and held it in 12 quarters.
- AlphaCrest Capital Management's Halozyme position peaked at $2.14M in Q3 2021.
- 423 funds tracked by Wall St. Rank held Halozyme as of Q4 2022.
Based on AlphaCrest Capital Management's 13F filing for Q4 2022.